as of 2026-10-27
Report date
Oct 27, 2026
Web data generated
2026-10-27 12:04 PM PDT
Alpha report generated
2026-10-27 12:03 PM PDT
Alpha web build revision 5e7e85d71312Alpha web package 20261027T190534125843Z-313fb7b0a7fe

INSM

Insmed

INSM

HealthcareBiotechnology$20.4B market cap
Meridian score73Top 30% of 695as of Oct 27Above average
ResearchNot researched
QualityD Quality: 20th percentile
MomentumD Momentum: 18th percentile
GrowthA Growth: 98th percentile
ValuationE Valuation: 1st percentile
ExpectationsA Expectations: 97th percentile

Evidence to review

  • Financial comparability: Operating profitability improved but remains weak, with a net loss.
Price and trend
Price$93.33
1M-20.8%
3M-10.4%
6M-31.4%
52w position2.4%
From high-56.1%
Relative volume1.1x
As ofOct 26, 2026
Above 21d: noAbove 50d: noAbove 200d: no50d over 200d: no
Back to the Meridian rank